The Penn State Cancer Institute is a cancer research center of the Penn State Milton S. Hershey Medical Center located in Hershey, Pennsylvania. The Institute provides clinical care, research, education, and community outreach services throughout central and eastern Pennsylvania.

During the past decade, Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 38 clinical trials were completed, i.e. on average, 345.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 17 clinical trials were completed. i.e. 1700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center" #1 sponsor was "Radiation Therapy Oncology Group" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Milton S. Hershey Medical Center" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Eastern Cooperative Oncology Group" with 5 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center" are "Breast Cancer" (9 trials), "Lung Cancer" (9 trials), "Leukemia" (6 trials), "Metastatic Cancer" (5 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center" in a lesser frequency.

Most popular intervention types in "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center" are "Drug" (57 trials), "Radiation" (28 trials), "Biological" (22 trials), "Procedure" (11 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (4 trials), "filgrastim" (4 trials) and "paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center" are 70 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, 17 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".